• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母乳喂养可减少阿片类物质暴露婴儿戒断治疗的需求。

Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.

机构信息

SERAF - Norwegian Centre for Addiction Research, University of Oslo, Oslo, Norway; Norwegian Directorate of Health, Oslo, Norway.

出版信息

Acta Paediatr. 2013 Nov;102(11):1060-6. doi: 10.1111/apa.12378. Epub 2013 Sep 2.

DOI:10.1111/apa.12378
PMID:23909865
Abstract

AIM

To examine the rate and duration of breastfeeding in a cohort of women in opioid maintenance treatment (OMT) in Norway, as well as the effect of breastfeeding on the incidence and duration of neonatal abstinence syndrome (NAS).

METHODS

A national cohort of 124 women treated with either methadone or buprenorphine during pregnancy, and their neonates born between 1999 and 2009, was evaluated in three study parts. A standardized questionnaire was administered, and medical information from the hospitals and municipalities were collected to confirm self-reported data.

RESULTS

There were high initiation rates of breastfeeding (77%) for women in OMT, but also high rates of early cessation of breastfeeding. Breastfed neonates exposed to methadone prenatally had significantly lower incidence of NAS requiring pharmacotherapy (53% vs. 80%), and both the whole group of infants and the methadone-exposed neonates needed shorter pharmacological treatment of NAS (p < 0.05) than neonates who were not breastfed.

CONCLUSION

Breastfed neonates exposed to OMT medication prenatally, and methadone-exposed newborns in particular, have lower incidence of NAS and require shorter pharmacotherapy for NAS than infants who are not breastfed. The results add to the evidence regarding the benefits of breastfeeding for neonates prenatally exposed to OMT medications.

摘要

目的

在挪威接受阿片类药物维持治疗(OMT)的女性队列中,检查母乳喂养的比例和持续时间,以及母乳喂养对新生儿戒断综合征(NAS)发生率和持续时间的影响。

方法

在三个研究部分中,评估了 1999 年至 2009 年期间接受美沙酮或丁丙诺啡治疗的 124 名孕妇及其新生儿组成的全国性队列。采用标准化问卷,并从医院和市政当局收集医疗信息以确认自我报告的数据。

结果

接受 OMT 的女性母乳喂养的初始比例很高(77%),但母乳喂养的早期中断率也很高。与未接受母乳喂养的婴儿相比,接受美沙酮产前暴露的母乳喂养新生儿发生需要药物治疗的 NAS 的发生率明显较低(53% vs. 80%),而且所有婴儿和接受美沙酮暴露的新生儿接受 NAS 药物治疗的时间也较短(p < 0.05)。

结论

与未接受母乳喂养的婴儿相比,接受 OMT 药物产前暴露的母乳喂养新生儿,尤其是接受美沙酮暴露的新生儿,发生 NAS 的发生率较低,NAS 的药物治疗时间也较短。这些结果增加了关于产前暴露于 OMT 药物的新生儿母乳喂养益处的证据。

相似文献

1
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.母乳喂养可减少阿片类物质暴露婴儿戒断治疗的需求。
Acta Paediatr. 2013 Nov;102(11):1060-6. doi: 10.1111/apa.12378. Epub 2013 Sep 2.
2
Breastfeeding rates and the relationship between breastfeeding and neonatal abstinence syndrome in women maintained on buprenorphine during pregnancy.孕期使用丁丙诺啡的女性母乳喂养率及母乳喂养与新生儿戒断综合征的关系。
J Midwifery Womens Health. 2013 Jul-Aug;58(4):383-8. doi: 10.1111/jmwh.12009.
3
Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.孕期阿片类药物维持治疗:新生儿戒断综合征的发生和严重程度。一项全国性前瞻性研究。
Eur Addict Res. 2009;15(3):128-34. doi: 10.1159/000210042. Epub 2009 Mar 31.
4
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.挪威 1996 年至 2009 年接受阿片类激动剂治疗的孕妇的全国队列研究:子宫内暴露于美沙酮或丁丙诺啡后新生儿结局。
Drug Alcohol Depend. 2013 Jan 1;127(1-3):200-6. doi: 10.1016/j.drugalcdep.2012.07.001. Epub 2012 Jul 25.
5
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.孕期阿片类药物依赖的丁丙诺啡和美沙酮治疗:两个连续病例系列中胎儿生长及新生儿结局的比较
Drug Alcohol Depend. 2008 Jul 1;96(1-2):69-78. doi: 10.1016/j.drugalcdep.2008.01.025. Epub 2008 Mar 19.
6
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.丁丙诺啡与美沙酮治疗阿片类药物依赖孕妇:对新生儿戒断综合征的影响
Drug Alcohol Depend. 2005 Jul;79(1):1-10. doi: 10.1016/j.drugalcdep.2004.11.013.
7
The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.婴儿喂养方式对暴露于美沙酮的婴儿新生儿戒断评分的影响。
Adv Neonatal Care. 2011 Aug;11(4):282-90. doi: 10.1097/ANC.0b013e318225a30c.
8
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.美沙酮与丁丙诺啡暴露新生儿戒断综合征体征特征的差异。
Addiction. 2012 Nov;107 Suppl 1(0 1):53-62. doi: 10.1111/j.1360-0443.2012.04039.x.
9
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.一项回顾性队列研究:宫内暴露于纳曲酮的新生儿的出生结局:与美沙酮、丁丙诺啡和非阿片类药物暴露的新生儿相比。
Drugs. 2017 Jul;77(11):1211-1219. doi: 10.1007/s40265-017-0763-8.
10
Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy.接受美沙酮维持治疗的女性所生婴儿发生新生儿戒断综合征的围产期危险因素。
Aust N Z J Obstet Gynaecol. 2010 Jun;50(3):253-8. doi: 10.1111/j.1479-828X.2010.01168.x.

引用本文的文献

1
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations.阿片类药物在孕产妇和儿科人群中的药物治疗研究现状及知识空白。
Pharmacotherapy. 2025 Jun;45(6):367-385. doi: 10.1002/phar.70024. Epub 2025 May 15.
2
Disrupted maternal behavior in morphine-dependent pregnant rats and anhedonia in their offspring.吗啡依赖的怀孕大鼠的母性行为紊乱及其后代的快感缺失。
Neuropharmacology. 2025 Jun 1;270:110372. doi: 10.1016/j.neuropharm.2025.110372. Epub 2025 Feb 17.
3
Disrupted Maternal Behavior in Morphine-Dependent Pregnant Rats and Anhedonia in their Offspring.
吗啡依赖的怀孕大鼠的母性行为紊乱及其后代的快感缺失
bioRxiv. 2024 Dec 31:2024.12.30.630830. doi: 10.1101/2024.12.30.630830.
4
Factors associated with medications for opioid use disorder (MOUD) treatment success during the pregnancy and postpartum periods: A scoping review.与孕期和产后期间阿片类药物使用障碍(MOUD)治疗成功相关的因素:范围综述。
Drug Alcohol Depend. 2024 Nov 1;264:112454. doi: 10.1016/j.drugalcdep.2024.112454. Epub 2024 Sep 28.
5
Managing the Mother-Baby Dyad Affected by Substance Disorder: A Statewide Quality Collaborative Initiative.管理受物质障碍影响的母婴对子:全州质量合作倡议。
Mo Med. 2024 May-Jun;121(3):212-219.
6
Advances in animal models of prenatal opioid exposure.产前阿片类药物暴露动物模型的研究进展。
Trends Neurosci. 2024 May;47(5):367-382. doi: 10.1016/j.tins.2024.03.005. Epub 2024 Apr 12.
7
An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics.新生儿阿片类戒断综合征及母婴特征的流行病学研究
Arch Womens Ment Health. 2024 Oct;27(5):863-867. doi: 10.1007/s00737-024-01460-2. Epub 2024 Apr 4.
8
The Finnegan Score for Neonatal Opioid Withdrawal Revisited With Routine Electronic Data: Retrospective Study.利用常规电子数据重新审视新生儿阿片类药物戒断的芬尼根评分:回顾性研究
JMIR Pediatr Parent. 2024 Feb 28;7:e50575. doi: 10.2196/50575.
9
Neonatal Abstinence Signs during Treatment: Trajectory, Resurgence and Heterogeneity.治疗期间的新生儿戒断症状:轨迹、复发与异质性
Children (Basel). 2024 Feb 5;11(2):203. doi: 10.3390/children11020203.
10
Methadone and neonatal abstinence syndrome (NAS): what we think we know, but do not.美沙酮与新生儿戒断综合征(NAS):我们自认为了解但实则并不了解的情况。
Front Pediatr. 2023 Dec 21;11:1316583. doi: 10.3389/fped.2023.1316583. eCollection 2023.